Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING RESPIRATORY DISEASE MEDIATED BY ALPHA-1 ANTITRYPSIN DEFICIENCY
No-Receipt date
2023-03634 - 31/10/2023
No-Filing date
20230402040 - 31/10/2023
No-Granting date
3113747 - 10/11/2023
No-EPO application date
21714345.2 - 16/03/2021
No-EPO granting date
4106757 - 23/08/2023
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2023 - 11/12/2023
Expiration date
17/03/2041
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
GB20200551916/04/2020/GB
GB20200552016/04/2020/GB
US202062706195 P04/08/2020/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 29/00
A61P 11/00
A61K 45/06
A61K 31/444
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1551782
MEREO BIOPHARMA 4 LIMITED
1 CAVENDISH PLACE
LONDON GREATER LONDON W1G 0QF
UNITED KINGDOM (GREAT BRITAIN)
Inventors
Code
Firstname
Surname
4029202
PARKIN, JACQUELINE
Representatives
Code
Firstname
Surname
Address
Town
Zip
3190
KONSTANTINOS
KILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8149
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Title Instruments
Payments history
5 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).